Sickle cell disease is a genetic hematological condition with multi-system manifestations. Various genotypes of the condition exist, each with their own risk of ocular manifestations. Sickle cell retinopathy, one of the more common ocular manifestations of sickle cell disease, can be potentially blinding and must be appropriately screened for, detected, and treated when necessary. Though there are no universally adopted preferred practice guidelines for the optometric/ophthalmic management of sickle cell retinopathy this course will provide attendees a foundation on sickle cell disease, the ocular manifestations of sickle cell disease, and the appropriate management of these patients. Case images will be presented and a discussion of when/who to refer will be included.

Course Code:



Daniel Epshtein, O.D.

Alanna Khattar-Sullivan, O.D.



AOA Expiration Date:


Related News

How the HIPAA Privacy Rule applies in a public health emergency

In response to Hurricane Ian, the federal government takes steps to ease the pains of disaster recovery in Florida. Learn more about the federal waivers—and how you can help colleagues affected by disaster.

AOA+ aims for new heights: 3,000 in DC for ’23

Learn more about AOA+ travel grant opportunities to attend this one-of-a-kind experience for optometry students, newly graduated doctors, and educators in Washington, D.C., June 21-24, 2023.

Partners in care

The AOA has created a trove of practice management tools and services that can power practices forward in a profession and health care landscape that increasingly demands doctors practice at their highest levels and creates greater opportunities to develop and empower paraoptometric staff. These days, change is out of necessity.